Indonèsia -
indonesi -
Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency
mabthera
boehringer ingelheim indonesia - indonesia - rituximab - cairan injeksi - 1400 mg/ 11,7 ml
Indonèsia -
indonesi -
Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency
mabthera
boehringer ingelheim indonesia - indonesia - rituximab - cairan injeksi - 10 mg/ml
Indonèsia -
indonesi -
Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency
mabthera
boehringer ingelheim indonesia - indonesia - rituximab - cairan injeksi - 10 mg/ml
Indonèsia -
indonesi -
Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency
cravit
kalbe farma - indonesia - levofloxacin hemihydrate - tablet salut selaput - 250 mg
Indonèsia -
indonesi -
Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency
cravit
kalbe farma - indonesia - levofloxacin hemihydrate - tablet salut selaput - 500 mg
Indonèsia -
indonesi -
Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency
cravit
kalbe farma - indonesia - levofloxacin hemihydrate - infus - 769 mg
Indonèsia -
indonesi -
Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency
cravit
kalbe farma - indonesia - levofloxacin hemihydrate - infus - 513 mg
Indonèsia -
indonesi -
Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency
cravit
kalbe farma - indonesia - levofloxacin hemihydrate - kaplet salut selaput - 750 mg
Indonèsia -
indonesi -
Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency
cravit
kalbe farma - indonesia - levofloxacin hemihydrate - tablet salut selaput - 257 mg
Indonèsia -
indonesi -
Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency
cravit
kalbe farma - indonesia - levofloxacin hemihydrate - tablet salut selaput - 512 mg